Exhibit at the Davosof Precision Medicine.
Meet 3,000+ precision medicine leaders where the scientific program and exhibition share the same traffic, then extend your presence through presentations, the meeting app, and high-value networking.
The science draws the room.
Since 2009, PMWC has brought together the people your customers, partners, and team want to meet.
Andrew NgGoogle Brain founder
Emmanuelle CharpentierCRISPR Nobel Laureate
David Baker2024 Nobel Laureate
Fei-Fei LiAI pioneer, Stanford
Eric LanderHuman Genome Project
Mary-Claire KingBRCA1 discovery pioneer
Daniel DruckerGLP-1 pioneer
Daphne KollerFounder & CEO, insitro
Not a side hall. Not an afterthought.
PMWC places exhibitors in the same physical flow as the five scientific tracks. Dedicated breaks, stage proximity, and a senior cross-sector audience create repeated opportunities for useful conversations.
Program-powered traffic
Booths sit beside the content that attracts your target market, not in a detached expo hall.
Senior, cross-sector access
Meet biopharma, diagnostics, health systems, AI, research, investors, payers, and policy leaders in one place.
More than a booth
Combine physical presence with presentations, digital visibility, lead retrieval, passes, meetings, and sponsorship options.
A decision-maker audience, not a badge-scan collection.
The audience spans the science, clinical adoption, product, policy, reimbursement, investment, and operating decisions that move precision medicine forward.
Top executives, CXOs, and directors
A high concentration of people who can approve partnerships, pilots, purchases, and strategic follow-up.
Pharma / Biotech
Novartis, Merck, Genentech, and more
Academia / Research
Stanford, UCSF, Duke, and more
Tools / Consumer
Illumina, PacBio, Thermo Fisher, and more
Medical Centers
Sutter Health, Stanford Health Care, Kaiser, and more
Health Providers
Aetna, UnitedHealth, Intermountain, and more
AI / Tech
OpenAI, Microsoft, Google, Tempus, and more
VC / Finance
KPCB, Sequoia, Khosla Ventures, and more
Regulatory / Reimbursement
FDA, NIH, European Commission, and more
Media
NBC, ABC, GenomeWeb, Bloomberg, and more
Patient Advocates / Foundations
Cancer Commons, Genetic Alliance, and more
Top Executive / CXO / Director
Research Scientist / PI
Physician / Clinician
AI / Data Scientist
Laboratory / Commercial Leaders
Investment, Sales, Advocacy & Other
PhD
MD
Advanced Degree
Degree categories overlap, reflecting attendees with multiple advanced credentials.
100+ countries take part in PMWC.
Meet a U.S.-centered audience with meaningful participation from Europe, Asia-Pacific, Africa, and the Middle East.
Choose the audience you want to be next to.
Five parallel scientific tracks let you align your exhibit presence with the buyers, partners, clinicians, and researchers most relevant to your company.
Track 1Next-Gen Therapeutics
- D1Engineered cell-based therapies
- D2Immunotherapies and targeted therapies
- D3Programmable genetic medicines
Best fit: cell, gene and RNA platforms; delivery; CRO/CDMO; manufacturing; assays; clinical-stage biotech.
Track 2AI & Computational Medicine
- D1AI in diagnostics, multimodal and actionable
- D2Clinical AI, deployment, decision support and RWE
- D3AI in drug discovery and computational biology
Best fit: AI/ML; cloud and compute; data platforms; clinical software; digital pathology; RWE; drug discovery.
Track 3Precision Diagnostics
- D1Early detection, from screening to interception
- D2Liquid biopsy, therapy guidance and monitoring
- D3Blood-based diagnostics beyond cancer
Best fit: MCED, MRD and liquid biopsy; sequencing; CDx; biomarkers; reference labs; assay and sample technologies.
Track 4Integrated Precision Medicine
- D1Genomic diagnosis and population screening
- D2Integration and implementation of precision medicine
- D3Precision aging, prevention and healthspan
Best fit: genomic medicine; long reads; EHR/CDS; interoperability; implementation; payers; population health; longevity.
Track 5Spatial & Translational Disease Biology
- D1Spatial biology and tissue architecture
- D2Precision immunology, autoimmune and inflammatory disease
- D3Precision neurology and brain health
Best fit: spatial and single-cell; immunology; neurology; imaging; digital biomarkers; translational services.
Start with the commercial outcome, then choose the package.
Visibility can be built around product awareness, qualified conversations, thought leadership, partner development, or a combination of all four.
Do not guess your package. Send the team your goal and budget range, and they will recommend the strongest available fit.
Help me chooseChoose a position, not just a booth number.
Use the live map directly below to compare current inventory with the track halls, networking areas, stage entrances, and attendee flow.
Click a booth on the map. You can register immediately or email the team to hold the strongest fit while you decide.
Choose the footprint, visibility, and access you need.
Prices below use the same live exhibit product logic as the current Silver, Bronze, and Copper cards, not attendee-ticket savings.
Silver Package
Largest footprint, premium placement
- Exhibit size: 22x20 island or inline 20x10, premium location
- Company presentation: 30 min (Day 1), for you or your client
- Included tickets: 5 full conference passes
- Lead retrieval: included
- Printed agenda listing: included
- Discounts on additional tickets: included
Bronze Package
Strong visibility, balanced ROI
- Exhibit size: inline 20x10 or 10x10, premium location
- Company presentation: 15 min (Day 2)
- Included tickets: 3 full conference passes
- Lead retrieval: included
- Printed agenda listing: included
- Discounts on additional tickets: included
Copper Package
Entry package, still real leads
- Exhibit size: inline 10x10
- Company presentation: not included
- Included tickets: 2 full conference passes
- Lead retrieval: included
- Printed agenda listing: not included
- Discounts on additional tickets: limited
See the exact audience around each track.
Open any track for the topics being discussed, the senior roles you can meet, and the companies best positioned to sponsor or exhibit alongside it.
Track 1: Next-Gen Therapeutics Engineering medicines that change the standard of care
What You’ll Explore
- Engineered cell therapies: CAR-T, TCR, TIL and NK
- Off-the-shelf and in vivo cell therapy platforms
- Breaking the solid-tumor barrier with immune engineering
- Next-generation IO, bispecifics, ADCs and targeted therapy
- Resistance biology, predictive biomarkers and adaptive combinations
- CRISPR, base/prime editing and programmable gene control
- RNA editing, splice modulation, ASOs, siRNA and mRNA
- In vivo delivery, vectors, LNPs and tissue targeting
- Manufacturing, evidence and access from N-of-1 to scale
Who You’ll Meet
- CEOs, Founders, CMOs, CSOs & Heads of R&D — biotech, pharma and advanced-therapy leadership
- Oncology, Hematology & Immunology Chairs — clinicians shaping treatment standards
- Heads of Cell Therapy, Gene Therapy & Genetic Medicines — discovery through translation
- SVPs/VPs of Translational Medicine & Biomarkers — patient selection and response strategy
- Clinical Development & Operations Executives — early-phase through pivotal trials
- Heads of CMC, Manufacturing, Quality & Supply Chain — scale-up and commercialization
- Regulatory, Safety & Pharmacovigilance Leaders — approval and lifecycle risk
- Market Access, Reimbursement & Payer Executives — evidence, coverage and patient access
- Business Development, External Innovation, Corporate Strategy & Venture Leaders — partnerships and capital
Best-Fit Sponsors
- Cell, gene, RNA and genome-editing platforms
- Vector, LNP and targeted-delivery technologies
- CDMOs, CROs and clinical-trial networks
- Cell processing, automation and manufacturing systems
- Potency, release, safety and biomarker assays
- Single-cell, spatial and multi-omics technologies
- ADC, antibody and protein-engineering platforms
- GMP, MES, QMS, eBR and regulatory software
- Cold-chain, logistics and patient-support services
- Clinical-stage biotechs seeking partners and investors
Track 2: AI & Computational Medicine AI that ships, scales, and discovers
What You’ll Explore
- Multimodal AI across pathology, imaging, genomics and EHR data
- Computational pathology beyond what the human eye can see
- AI-enabled companion diagnostics and patient selection
- Clinical AI agents and decision support in real workflows
- Foundation models for human biology and medicine
- AI-powered clinical trials and regulatory-grade RWE
- Target discovery, protein design and generative chemistry
- Data infrastructure, MLOps and enterprise deployment
- Safety, governance, evaluation and equitable performance
Who You’ll Meet
- CEOs, Chief AI Officers, Chief Digital Officers & Chief Data Officers — health AI and biopharma leadership
- CIOs, CTOs, CMIOs & Chief Analytics Officers — enterprise clinical deployment
- Heads of AI/ML, Data Science & Computational Biology — pharma, diagnostics and health systems
- Radiology, Pathology & Clinical Informatics Chairs — frontline adoption and validation
- SVPs/VPs of Clinical Development, RWE & Trial Innovation — evidence generation
- Product, Engineering, Platform & MLOps Executives — shipping regulated AI at scale
- Heads of Governance, Safety, Privacy & Cybersecurity — trustworthy deployment
- Digital Health Founders & Clinical Product Leaders — workflow and patient solutions
- Corporate Strategy, Business Development, External Innovation & Investors — partnerships and growth
Best-Fit Sponsors
- Cloud, GPU, accelerator and high-performance-compute providers
- EHR, CDS and interoperability platforms
- Imaging, digital-pathology, PACS and edge-device vendors
- FHIR, ETL, data-lake and enterprise analytics platforms
- Model evaluation, governance, monitoring and audit tools
- RWE, HEOR and clinical-trial analytics companies
- Privacy, security, consent and identity providers
- AI drug-discovery and laboratory-automation platforms
- Annotation, curation and synthetic-data providers
- Digital-health and clinical-AI companies ready to scale
Track 3: Precision Diagnostics Detect earlier, treat smarter, monitor continuously
What You’ll Explore
- Risk-stratified screening and the next generation of early detection
- Methylation, fragmentomics, host response and multimodal signals
- MRD as a treatment-decision engine
- Longitudinal monitoring of resistance, response and relapse
- Companion diagnostics for IO, ADCs and cell therapy
- Integrating tissue, liquid, imaging and clinical biomarkers
- ClinOmics in real clinical practice
- Transplant and organ-health monitoring from blood
- Metagenomic diagnostics for infection and the undiagnosed
- Maternal-fetal diagnostics and actionable non-cancer blood tests
Who You’ll Meet
- CEOs, CMOs, CSOs & Heads of Diagnostics — assay and platform-company leadership
- Oncology, Pathology & Laboratory Medicine Chairs — clinical adoption and standards
- Medical & Scientific Directors of CLIA/CAP Laboratories — validation and operations
- SVPs/VPs of Biomarkers, Companion Diagnostics & Translational Medicine — therapy guidance
- Heads of Early Detection, MRD & Disease Monitoring — oncology and beyond
- Clinical Chiefs in Transplant, Infectious Disease & Maternal-Fetal Medicine — emerging blood-based applications
- Bioinformatics, Computational Genomics & Assay Development Executives — signal to interpretation
- Payer, HTA, Market Access & Health Economics Leaders — utility, coverage and reimbursement
- Regulatory, Quality, Pharma Alliance, Corporate Strategy & Diagnostics Investment Leaders — approval and commercialization
Best-Fit Sponsors
- MCED, MRD and liquid-biopsy platforms
- Multi-disease blood-based diagnostic companies
- Methylation, fragmentomics, cfRNA, EV and proteomic technologies
- Short- and long-read sequencing, sample prep and assay chemistry
- AI diagnostics, interpretation and decision-support software
- Reference laboratories and CLIA testing services
- CDx co-development and clinical-trial assay partners
- Biobanking, pre-analytics, automation and cold-chain providers
- Standards, quality and proficiency-testing organizations
- Market-access, reimbursement and regulatory advisors
Track 4: Integrated Precision Medicine From sequence to system-wide precision care
What You’ll Explore
- Rare-disease diagnosis beyond the exome
- Newborn sequencing and population genomic screening
- Structural variants, long reads and closing the diagnostic gap
- Moving from genomic diagnosis to targeted treatment
- Precision-medicine operating models that actually work
- EHR integration and decision support clinicians will use
- Coverage, evidence and value-based implementation
- Community access, equity and population-scale delivery
- Aging biology, GLP-1 and prevention
- Biomarkers, wearables and clinical trials for healthspan
Who You’ll Meet
- Health-System CEOs, CMOs, CSOs, CIOs & Chief Strategy Officers — enterprise precision care
- Heads of Genomic Medicine, Rare Disease & Molecular Diagnostics — sequence to action
- Genetics, Pediatrics & Laboratory Medicine Chairs — newborn and rare-disease programs
- SVPs/VPs of Precision Medicine, Population Health & Clinical Transformation — system-wide implementation
- Heads of Bioinformatics, Data Architecture, LIS/LIMS & Interoperability — the operating backbone
- Payer, Value-Based Care, Quality & Evidence Executives — coverage and outcomes
- Heads of Clinical Decision Support, Digital Health & Innovation — workflow adoption
- Geroscience, Metabolic Health & Longevity Institute Leaders — prevention and healthspan
- Business Development, Corporate Strategy, External Innovation & Investors — scaling new models
Best-Fit Sponsors
- WGS, WES, long-read and newborn-screening partners
- Variant interpretation, curation and knowledgebase platforms
- EHR, interoperability and clinical-decision-support vendors
- Cloud data, analytics, governance and integration platforms
- LIS, LIMS, metadata, lineage and workflow systems
- Biobank, registry and sample-management companies
- Payers and value-based-care partners
- Implementation and change-management consultancies
- Aging biomarkers, wearables and digital-endpoint companies
- Prevention, metabolic-health and longevity innovators
Track 5: Spatial & Translational Disease Biology Map tissue, reset immunity, decode the brain
What You’ll Explore
- Spatial transcriptomics, proteomics and tissue architecture
- Human cell atlases and cell-state-driven target discovery
- Spatial pathology, foundation models and clinical biomarkers
- Scaling spatial technologies from discovery to diagnostics
- Immune reset and CAR-T approaches in autoimmune disease
- Tolerance, Tregs and durable disease modification
- Immune signatures, patient stratification and smarter trials
- Blood biomarkers for Alzheimer’s and neurodegeneration
- Precision diagnosis across stroke, epilepsy, Parkinson’s, ALS and FTD
- AI neuroimaging, digital biomarkers and circuit-based therapies
Who You’ll Meet
- CEOs, CMOs, CSOs & Heads of R&D — spatial biology, immunology and neuroscience companies
- Heads of Spatial Biology, Single-Cell Science & Tissue Profiling — atlas to application
- Pathology, Immunology, Rheumatology, Neurology & Neuroscience Chairs — cross-disease clinical leadership
- SVPs/VPs of Translational Medicine, Biomarkers & Precision Research — patient stratification
- Heads of Autoimmune, Neurodegeneration & Brain Health Programs — emerging treatment categories
- Clinical Development, Trial Strategy & Medical Affairs Executives — proof to practice
- Imaging, Digital Biomarker, AI & Computational Biology Leaders — multimodal precision phenotyping
- Business Development, External Innovation & Corporate Strategy Executives — scientific and commercial partnerships
- Venture, Growth & Strategic Investors — building the next precision frontier
Best-Fit Sponsors
- Spatial transcriptomics, proteomics and imaging platforms
- Single-cell, tissue-analysis and digital-pathology technologies
- AI foundation-model and spatial-informatics companies
- Autoimmune and inflammatory-disease biopharma
- Immune-reset, tolerance, Treg and cell-therapy platforms
- Neurodiagnostic, blood-biomarker and reference-lab companies
- Neuroimaging AI, EEG, wearable and digital-biomarker platforms
- Neurology CROs, imaging cores and trial-technology providers
- Biobanks, tissue networks and translational-service partners
- Clinical-stage companies seeking scientific and commercial partners
Selected recent PMWC sponsors & exhibitors
Curated examples from 2026 and 2027, not a complete roster.
The value is access, relevance, and follow-up.
The strongest comments are not about booth furniture. They are about the people reached and the conversations that continued after PMWC.
Our booth attracted significant attention and became a hub for meaningful conversations. We connected with global experts and industry leaders, sparking new collaborations and follow-up partnerships after the event.
Everyone at the meeting is a high-level decision-maker and extremely open to discussions in a way that you cannot find at other conferences, providing access that could otherwise take months.
PMWC is one of the best conferences I have attended in many, many years. PMWC is indeed the Davos of Biotech.
The practical details.
Enough information to decide whether the conversation is worth having. The team can handle the rest quickly.
Where are the exhibit booths located?
The exhibition is integrated with the five track halls and main attendee traffic. Use the live map above to see current locations and their proximity to specific program areas.
Can an exhibit package include a company presentation?
Presentation opportunities are available with selected packages or partnerships, subject to program fit and remaining inventory. Ask the team to recommend the cleanest combination.
What package is right for a first-time exhibitor?
That depends on whether your priority is simple presence, qualified meetings, a presentation, additional passes, or a larger footprint. A short email with your goal and budget is enough for a recommendation.
Are custom exhibit and sponsorship combinations available?
Yes, when inventory allows. Booths can be paired with branding, program, reception, digital, meeting, or ticket options to create a more focused presence.
When does current pricing change?
The current pricing deadline is AUG. 13. Rates and the best locations generally become less favorable as inventory is claimed.
How do I confirm current availability?
Email [email protected] or call +1 650-961-8877. Include your preferred booth size, program track, and whether a presentation matters.
Tell us who you need to reach.
We will match your objective to the strongest available footprint, program adjacency, and visibility mix, without forcing you into the wrong package.
PMWC – Leading & Original Conference for Precision Medicine CO-HOSTED BY:
